| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.00059 | 1 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.00056 | 1 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.00028 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.00029 | 1 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.00026 | 1 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.00018 | 1 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.00019 | 1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -7.2e-05 | 1 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 6.1e-05 | 1 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -5.1e-05 | 1 |